By 2025, global spending on pharmaceutical (pharma) products will reach US$1.6 trillion, according to a report from IQVIA. And that doesn’t even include the current US$220 billion spent on chemicals, raw materials, excipients, and other Active Pharmaceutical Ingredients (APIs) that are needed to produce finished medicines. This demand, in tandem with a strict regulatory environment, necessitates the need for Internet of Things (IoT) technologies that provide rich data and analytical insight into logistical operations.
Although pharma stakeholders may be delighted about the increased demand for medicines and other products, this presents an enormous supply chain challenge. Not only are there larger quantities of shipments that the average pharma must track, but there are also numerous parties that have a role to play in the supply chain. This just makes product visibility trickier than it already is.
Between higher volumes and lower price points, pharmaceutical manufacturers must seek new ways to keep margins high. Reducing the costs associated with the supply chain has become a popular method to recoup diminishing returns. After speaking with a variety of leaders in the pharmaceutical space, ABI Research has learned a lot about the diverse set of supply chain challenges that these organizations face, which can all be solved with tracking technologies and subsequent data analytics insight. Some of those challenges include theft, misplacement, diversions, environmental regulation, and delivery expectations.
By tracking the movement of pharmaceutical products throughout the supply chain, and even monitoring a product’s properties like temperature levels, IoT tracking technologies can help decision-makers choose the right packaging type, optimize shipping routes, control inventory, shift the mode of transport or delivery speed, and change service levels from partners. With End-to-End (E2E) visibility, a company can gain a broader overview of its delivery network and how to cut logistical costs.
In addition to providing improved supply chain visibility through data analytics, tracking pharmaceutical products is also a growing necessity given the intensified serialization regulatory environment in numerous countries. For example, the U.S Drug Supply Chain Security Act (DSCSA)—responsible for regulating the world’s largest pharmaceutical market—is pushing for a wide range of tracing abilities for medicines and other products in the pharma supply chain.
Below explains the various technologies that can be applied to the pharma supply chain.
Learn more about how they’re utilizing assets
Automate inventory data collection
Track pallets and crates
As of now, the use of RFID is relatively rare, with only 11% of U.S. hospitals using RFID-based infrastructure.
COVID-19, and its subsequent effect on the global supply chain, highlighted the importance of supply chain visibility. IoT tracking technologies, especially as they merge with analytics and Real-Time Tracking Visibility (RTTV) software, offer pharma logistics teams the best solution when it comes to optimizing processes in a way that meets delivery times, adheres to regulations, and ensures quality assurance.
In every region of the world, tracking software and services in pharmaceuticals are going to continue to be in high demand. Between 2019 and 2026, the North American market will increase the number of journeys served from 9.9 million to 51.6 million journeys. In Europe and Asia-Pacific, the number of supply chain journeys that pharma tracking technologies will serve will come out to 34.1 million and 6 million journeys by 2026, respectively.
To learn more about the pharma supply chain—and the IoT analytics business cases in this space—read ABI Research’s IoT and Supply Chain Visibility in the Pharmaceutical Industry: Ecosystem Assessment report (AN-5352). This report is part of the company’s IoT Markets research service, which includes research, data, and ABI Insights.